Publisher: Elsevier

Related content
Volume 7, Number 17, 9 September 1997

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Synthesis of 7-membered cyclic hydroxyguanidines: novel HIV-1 protease inhibitors
pp. 2145-2148(4)
Authors: Jadhav, P.K.; Woerner, F.J.; Man, H.

Favourites:Add to Favourites

Serotonin 5-HT4 agonist activity of a series of meso-azanoradamantane benzamides
pp. 2149-2154(6)
Authors: Becker, D.P.; Nosal, R.; Villamil, C.I.; Gullikson, G.; Moummi, C.; Yang, D.; Flynn, D.L.

Favourites:Add to Favourites

Hemisynthesis of rhazinilam analogues: structure - activity relationships on tubulin-microtubule system
pp. 2155-2158(4)
Authors: David, B.; Sevenet, T.; Thoison, O.; Awang, K.; Pais, M.; Wright, M.; Guenard, D.

Favourites:Add to Favourites

Synthesis and in vitro cytotoxicity of aminocoumarin platinum(II) complexes
pp. 2165-2168(4)
Authors: Kokotos, G.; Theodorou, V.; Tzougraki, C.; deforce, D.L.D.; van den Eeckhout, E.G.

Favourites:Add to Favourites

Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase
pp. 2169-2172(4)
Authors: Frechette, R.F.; Ackerman, C.; Beers, S.; Look, R.; Moore, J.

Favourites:Add to Favourites

Parallel-stranded duplex DNA formed by a new base pair between guanine and 5-aza-7-deazaguanine
pp. 2173-2176(4)
Authors: Seela, F.; Melenewski, A.; Changfu, W.

Favourites:Add to Favourites

Synthesis and receptor binding studies of quinolinic derivatives as melatonin receptor ligands
pp. 2177-2180(4)
Authors: Li, P.; Chu, G.; Gillen, M.L.; Witt-Enderby, P.A.

Favourites:Add to Favourites

Structure-based design of non-peptidic pyridone aldehydes as inhibitors of interleukin-1 converting enzyme
pp. 2181-2186(6)
Authors: Golec, J.M.C.; Mullican, M.D.; Murcko, M.A.; Wilson, K.P.; Kay, D.P.; Jones, S.D.; Murdoch, R.; Bemis, G.W.; Raybuck, S.A.; Luong, Y.; Livingston, D.J.

Favourites:Add to Favourites
Favourites:Add to Favourites

C32-amino derivatives of the immunosuppressant ascomycin
pp. 2199-2204(6)
Authors: Ok, H.O.; Szumiloski, J.L.; Beattie, T.R.; Goulet, M.T.; Staruch, M.J.; Dumont, F.J.; Wyvratt, M.J.

Favourites:Add to Favourites

Design and synthesis of conformationally constrained arginal thrombin inhibitors
pp. 2205-2210(6)
Authors: Salimbeni, A.; Paleari, F.; Canevotti, R.; Criscuoli, M.; Lippi, A.; Angiolini, M.; Belvisi, L.; Scolastico, C.; Colombo, L.

Favourites:Add to Favourites

4-Heterocyclyl tetrahydropyridines as selective ligands for the human dopamine D4 receptor
pp. 2211-2216(6)
Authors: Haworth, K.E.; Harrison, T.; Kulagowski, J.J.; Leeson, P.D.; Owens, A.P.; Ridgill, M.P.; Teall, M.R.; Fielding, M.; Chapman, K.; Emms, F.; Marwood, R.; Patel, S.; Moss, K.L.

Favourites:Add to Favourites

Synthesis and biological activity of novel penem sulfoxides and sulfones
pp. 2217-2222(6)
Authors: Pfaendler, H.R.; Weishaupt, R.; Medicus, C.

Favourites:Add to Favourites

Discovery of Ro 48-5695: a potent mixed endothelin receptor antagonist optimized from Bosentan
pp. 2223-2228(6)
Authors: Neidhart, W.; Breu, V.; Burri, K.; Clozel, M.; Hirth, G.; Klinkhammer, U.; Giller, T.; Ramuz, H.

Favourites:Add to Favourites

11,21-Bisphenyl-19-norpregnane derivatives are selective antiglucocorticoids
pp. 2229-2234(6)
Authors: Gebhard, R.; van der Voort, H.; Schuts, W.; Schoonen, W.

Favourites:Add to Favourites

BN 80245: an E-ring modified camptothecin with potent antiproliferative and topoisomerase I inhibitory activities
pp. 2235-2238(4)
Authors: Lavergne, O.; Lesueur-Ginot, L.; Rodas, F.P.; Bigg, D.C.H.

Favourites:Add to Favourites

Novel inhibitors of influenza sialidases related to zanamivir - Heterocyclic replacements of the glycerol sidechain
pp. 2239-2242(4)
Authors: Smith, P.W.; Whittington, A.R.; Sollis, S.L.; Howes, P.D.; Taylor, N.R.

Favourites:Add to Favourites

Synthesis of rhenium(I) and technetium(I) carbonyl/dithioether ligand complexes bearing 3,17-estradiol
pp. 2243-2246(4)
Authors: Reisgys, M.; Wust, F.; Alberto, R.; Schibli, R.; Schubiger, P.A.; Pietzsch, H.; Spies, H.; Johannsen, B.

Favourites:Add to Favourites

Solid Phase Synthesis of C-Terminal Carbohydrate Modified Enkephalins
pp. 2247-2250(4)
Authors: Drouillat, B.; Kellam, B.; dekany, G.; Starr, M.S.; Toth, I.

Favourites:Add to Favourites

The efficient synthesis of a bis-glycosylated steroid drug transport reagent: methyl 3--amino-7α, 12α-DI(1'α-glucosyl)-5-cholate (TC002)
pp. 2251-2254(4)
Authors: Sofia, M.J.; Kakarla, R.; Kogan, N.; Dulina, R.; Hui, Y.W.; Hatzenbuhler, N.T.; Liu, D.; Chen, A.; Wagler, T.

Favourites:Add to Favourites

Unprecedented detoxification of the cruciferous phytoalexin camalexin by a root phytopathogen
pp. 2255-2260(6)
Authors: Soledade, M.; Pedras, C.; Khan, A.Q.

Favourites:Add to Favourites

Synthesis of new 3-thiosubstituted carbacephem antibiotics and their activity against penicillin resistant streptococcus pneumoniae
pp. 2261-2264(4)
Authors: Blaszczak, L.C.; Eid, C.N.; Flokowitsch, J.; Gregory, G.S.; Hitchcock, S.A.; Huffman, G.W.; Mayhugh, D.R.; Nesler, M.J.; Preston, D.A.; Zia-Ebrahimi, M.

Favourites:Add to Favourites

The inhibition of glutamate racemase by d-N-hydroxyglutamate
pp. 2265-2270(6)
Authors: Glavas, S.; Tanner, M.E.

Favourites:Add to Favourites

Arylacetamide kappa-selective opioid ligands
pp. 2271-2276(6)
Authors: Pechulis, A.D.; Archer, S.; Wentland, M.P.; Colasurdo, A.M.; Bidlack, J.M.

Favourites:Add to Favourites
Favourites:Add to Favourites

Anti-Histaminic Activity of Bromopyrrole Alkaloids Isolated from Caribbean Agelas Sponges
pp. 2283-2288(6)
Authors: Cafieri, F.; Carnuccio, R.; Fattorusso, E.; Taglialatela-Scafati, O.; Vallefuoco, T.

Favourites:Add to Favourites

Synthesis and biological activities of new heterocyclic aromatic retinoids
pp. 2289-2294(6)
Authors: Diaz, P.; Michel, S.; Stella, L.; Charpentier, B.

Favourites:Add to Favourites

Orevactaene, a novel binding inhibitor of HIV-1 Rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880
pp. 2295-2298(4)
Authors: Shu, Y.; Qingmei, Y.; Hui, L.; Kadow, K.F.; Hussain, R.A.; Huang, S.; Gustavson, D.R.; Lowe, S.E.; Chang, L.; Pirnik, D.M.; Kodukula, K.

Favourites:Add to Favourites

Design and synthesis of the cartilage protective agent (CPA, Ro32-3555)
pp. 2299-2302(4)
Authors: Broadhurst, M.J.; Brown, P.A.; Lawton, G.; Ballantyne, N.; Borkakoti, N.; Bottomley, K.M.K.; Cooper, M.I.; Eatherton, A.J.; Kilford, I.R.; Malsher, P.J.; Nixon, J.S.; Lewis, E.J.; Sutton, B.M.; Johnson, W.H.

Favourites:Add to Favourites

An aromatic moiety is not essential for pharmacophore binding to sigma binding sites: synthesis of n-alkylazacycloheptane derivatives as potent sigma ligands
pp. 2303-2306(4)
Authors: Yamashita, A.; Takahashi, N.; Mochizuki, D.; Tsujita, R.; Yamada, S.; Kawakubo, H.; Suzuki, Y.; Watanabe, H.

Favourites:Add to Favourites

3-substituted-4-hydroxy-7-chromanylacetic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor
pp. 2307-2312(6)
Authors: Reiter, L.A.; Melvin, L.S.; Crean, G.L.; Showell, H.J.; Koch, K.; Biggers, M.S.; Cheng, J.B.; Breslow, R.; Conklyn, M.J.; Farrell, C.A.; Hada, W.A.; Laird, E.R.; Martin, J.J.; Miller, G.T.; Pillar, J.S.

Favourites:Add to Favourites

Synthesis and receptor binding affinity of conformationally restricted retinoic acid analogues
pp. 2313-2318(6)
Authors: Man, F.W.; Repa, J.J.; Clagett-Dame, M.; Curley, R.W.

Favourites:Add to Favourites

The design and synthesis of orally active short duration spiroindane growth hormone secretagogues
pp. 2319-2324(6)
Authors: Tata, J.R.; Lu, Z.; Jacks, T.M.; Schleim, K.D.; Cheng, K.; Wei, L.; Chan, W.W.; Butler, B.; Tsou, N.; Leung, K.; Chiu, S.; Hickey, G.; Smith, R.G.; Patchett, A.A.

Favourites:Add to Favourites

Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro
pp. 2325-2328(4)
Authors: Lin, Y.; Zembower, D.E.; Flavin, M.T.; Schure, R.M.; Anderson, H.M.; Korba, B.E.; Chen, F.

Favourites:Add to Favourites

Additions and corrections
pp. 2329-2329(1)
Authors: Kamal, A.; Reddy, B.S.N.; Reddy, B.S.P.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more